Consuming functional foods enriched with plant sterol or stanol esters for 85 weeks does not affect neurocognitive functioning or mood in statin-treated hypercholesterolemic individuals

Journal of Nutrition

Volumn 139, Issue 7, 2009, Pages 1368-1373

  Schiepers, Olga J G ^a   De Groot, Renate H M ^a   Van Boxtel, Martin P J ^a   Jolles, Jelle ^a   De Jong, Ariënne ^b   Lütjohann, Dieter ^c   Plat, Jogchum ^b   Mensink, Ronald P ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPESTANOL; CAMPESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MARGARINE; PHYTOSTEROL; SITOSTANOL; SITOSTEROL; STANOL ESTER; STIGMASTEROL; PLACEBO; SITOSTEROL DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE FAILURE QUESTIONNAIRE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FAT INTAKE; FEMALE; FOOD COMPOSITION; HUMAN; HYPERCHOLESTEROLEMIA; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; MOOD; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYMPTOM CHECKLIST 90; ADOLESCENT; AFFECT; BLOOD PRESSURE; DIET; DRUG EFFECT; LEARNING; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; THINKING; VASCULAR ENDOTHELIUM;

ANIMALIA;

ADOLESCENT; ADULT; AFFECT; AGED; BLOOD PRESSURE; COGNITION; DIET; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; LEARNING; MALE; MARGARINE; MEMORY; MIDDLE AGED; PHYTOSTEROLS; PLACEBOS; SITOSTEROLS; THINKING; YOUNG ADULT;

EID: 67649967959     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.108.103721     Document Type: Article

References (59)

1. Normén L, Johnsson M, Andersson H, Van Gameren Y, Dutta P. Plant sterols in vegetables and fruits commonly consumed in Sweden. Eur J Nutr. 1999;38:84-9.
2. Valsta LM, Lemström A, Ovaskainen ML, Lampi AM, Toivo J, Korhonen T, Piironen V. Estimation of plant sterol and cholesterol intake in Finland: quality of new values and their effect on intake. Br J Nutr. 2004;92:671-8.
3. Heinemann T, Kullak-Ublick GA, Pietruck B, Von Bergmann K. Mechanisms of action of plant sterols on inhibition of cholesterol absorption. Comparison of sitosterol and sitostanol. Eur J Clin Pharmacol. 1991;40 Suppl 1:S59-63.
4. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med. 1995;333:1308-12.
5. Normén L, Dutta P, Lia A, Andersson H. Soy sterol esters and betasitostanol ester as inhibitors of cholesterol absorption in human small bowel. Am J Clin Nutr. 2000;71:908-13.
6. Scientific concepts of functional foods in Europe. Consensus document. Br J Nutr. 1999;81 Suppl 1:S1-27.
7. Blair SN, Capuzzi DM, Gottlieb SO, Nguyen T, Morgan JM, Cater NB. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am J Cardiol. 2000;86:46-52.
8. Plat J, Mensink RP. Plant stanol and sterol esters in the control of blood cholesterol levels: mechanism and safety aspects. Am J Cardiol. 2005;96:D15-22.
9. Hendriks HF, Brink EJ, Meijer GW, Princen HM, Ntanios FY. Safety of long-term consumption of plant sterol esters-enriched spread. Eur J Clin Nutr. 2003;57:681-92.
10. Heinemann T, Axtmann G, Von Bergmann K. Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J Clin Invest. 1993;23:827-31.
11. Ostlund RE Jr, McGill JB, Zeng CM, Covey DF, Stearns J, Stenson WF, Spilburg CA. Gastrointestinal absorption and plasma kinetics of soy Delta(5)-phytosterols and phytostanols in humans. Am J Physiol Endocrinol Metab. 2002;282:E911-6.
12. Hallikainen MA, Sarkkinen ES, Uusitupa MI. Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner. J Nutr. 2000;130:767-76.
13. Plat J, Kerckhoffs DA, Mensink RP. Therapeutic potential of plant sterols and stanols. Curr Opin Lipidol. 2000;11:571-6.
14. Hepburn PA, Horner SA, Smith M. Safety evaluation of phytosterol esters. Part 2. Subchronic 90-day oral toxicity study on phytosterol esters: a novel functional food. Food Chem Toxicol. 1999;37:521-32.
15. Turnbull D, Whittaker MH, Frankos VH, Jonker D. 13-Week oral toxicity study with stanol esters in rats. Regul Toxicol Pharmacol. 1999;29:216-26.
16. Sanders DJ, Minter HJ, Howes D, Hepburn PA. The safety evaluation of phytosterol esters. Part 6. The comparative absorption and tissue distribution of phytosterols in the rat. Food Chem Toxicol. 2000;38:485-91.
17. Borgström B. Quantitative aspects of the intestinal absorption and metabolism of cholesterol and beta-sitosterol in the rat. J Lipid Res. 1968;9:473-81.
18. Jurevics H, Morell P. Cholesterol for synthesis of myelin is made locally, not imported into brain. J Neurochem. 1995;64:895-901.
19. Dietschy JM, Turley SD. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res. 2004;45:1375-97.
20. Plat J, De Jong A, Volger OL, Princen HM, Mensink RP. Preferential campesterol incorporation into various tissues in apolipoprotein E*3-Leiden mice consuming plant sterols or stanols. Metabolism. 2008;57:1241-7.
21. Teunissen CE, Mulder M, De Vente J, Von Bergmann K, De Bruijn C, Steinbusch HW, Lütjohann D. Concentrations of different sterols in the striatum and serum of 3-nitropropionic acid-treated Wistar and Lewis rats. Neurochem Res. 2001;26:1237-44.
22. Jansen PJ, Lütjohann D, Abildayeva K, Vanmierlo T, Plosch T, Plat J, Von Bergmann K, Groen AK, Ramaekers FC, et al. Dietary plant sterols accumulate in the brain. Biochim Biophys Acta. 2006;1761:445-53.
23. Fricke CB, Schroder M, Poulsen M, Von Bergmann K, Wester I, Knudsen I, Mortensen A, Lütjohann D. Increased plant sterol and stanol levels in brain of Watanabe rabbits fed rapeseed oil derived plant sterol or stanol esters. Br J Nutr. 2007;98:890-9.
24. Heverin M, Bogdanovic N, Lütjohann D, Bayer T, Pikuleva I, Bretillon L, Diczfalusy U, Winblad B, Björkhem I. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J Lipid Res. 2004;45:186-93.
25. Lütjohann D, Brzezinka A, Barth E, Abramowski D, Staufenbiel M, Von Bergmann K, Beyreuther K, Multhaup G, Bayer TA. Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain. J Lipid Res. 2002;43:1078-85.
26. Yu L, Von Bergmann K, Lütjohann D, Hobbs HH, Cohen JC. Selective sterol accumulation in ABCG5/ABCG8-deficient mice. J Lipid Res. 2004;45:301-7.
27. Halling KK, Slotte JP. Membrane properties of plant sterols in phospholipid bilayers as determined by differential scanning calorimetry, resonance energy transfer and detergent-induced solubilization. Biochim Biophys Acta. 2004;1664:161-71.
28. Leikin AI, Brenner RR. Fatty acid desaturase activities are modulated by phytosterol incorporation in microsomes. Biochim Biophys Acta. 1989;1005:187-91.
29. Wasser CR, Ertunc M, Liu X, Kavalali ET. Cholesterol-dependent balance between evoked and spontaneous synaptic vesicle recycling. J Physiol. 2007;579:413-29.
30. Pucadyil TJ, Chattopadhyay A. Role of cholesterol in the function and organization of G-protein coupled receptors. Prog Lipid Res. 2006;45:295-333.
31. Kotti TJ, Ramirez DM, Pfeiffer BE, Huber KM, Russell DW. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc Natl Acad Sci USA. 2006;103:3869-74.
32. De Jong A, Plat J, Lütjohann D, Mensink RP. Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment. Br J Nutr. 2008;100:937-41.
33. Plat J, Mensink RP. Vegetable oil based versus wood based stanol ester mixtures: effects on serum lipids and hemostatic factors in nonhypercholesterolemic subjects. Atherosclerosis. 2000;148:101-12.
34. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-98.
35. Van der Elst W, Van Boxtel MPJ, Van Breukelen GJP, Jolles J. Rey's verbal learning test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc. 2005;11:290-302.
36. Van der Elst W, Van Boxtel MPJ, Van Breukelen GJP, Jolles J. The Stroop color-word test: influence of age, sex, and education; and normative data for a large sample across the adult age range. Assessment. 2006;13:62-79.
37. Van der Elst W, Van Boxtel MPJ, Van Breukelen GJP, Jolles J. The Concept Shifting Test: adult normative data. Psychol Assess. 2006;18:424-32.
38. Van der Elst W, Van Boxtel MPJ, Van Breukelen GJP, Jolles J. The Letter Digit Substitution Test: normative data for 1,858 healthy participants aged 24-81 from the Maastricht Aging Study (MAAS): influence of age, education, and sex. J Clin Exp Neuropsychol. 2006;28:998-1009.
39. Lezak MD, Howieson DB, Loring DW. Neuropsychological assessment. 4th ed. New York: Oxford University Press; 2004.
40. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982;21:1-16.
41. Ponds RWHM. Forgetfulness and cognitive aging: prevalence, characteristics, and determinants. Maastricht (The Netherlands): Maastricht University; 1998.
42. Arrindell WA, Ettema JHM. SCL-90. Een multidimensionele psychopathologie-indicator (Dutch) [SCL-90. A multidimensional indicator of psychopathology]. Lisse (The Netherlands): Swets & Zeitlinger; 1986.
43. De Bie SE. Standaardvragen 1987: voorstellen voor uniformering van vraagstellingen naar achtergrondkenmerken en interviews (Dutch) [Standard questions 1987: proposal for uniformization of questions regarding background variables and interviews]. 2nd ed. Leiden (The Netherlands): Leiden University Press; 1987.
44. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale (NJ): Erlbaum; 1988.
45. Salen G, Patel S, Batta AK. Sitosterolemia. Cardiovasc Drug Rev. 2002;20:255-70.
46. Kidambi S, Patel SB. Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis. J Clin Pathol. 2008;61:588-94.
47. Lütjohann D, Breuer O, Ahlborg G, Nennesmo I, Sidén A, Diczfalusy U, Björkhem I. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci USA. 1996;93:9799-804.
48. De Groot RHM, Vuurman EF, Hornstra G, Jolles J. Differences in cognitive performance during pregnancy and early motherhood. Psychol Med. 2006;36:1023-32.
49. Van Boxtel MPJ, Menheere PPCA, Bekers O, Hogervorst E, Jolles J. Thyroid function, depressed mood, and cognitive performance in older individuals: the Maastricht Aging Study. Psychoneuroendocrinology. 2004;29:891-8.
50. Durga J, Van Boxtel MPJ, Schouten EG, Kok FJ, Jolles J, Katan MB, Verhoef P. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet. 2007;369:208-16.
51. Dullemeijer C, Durga J, Brouwer IA, Van de Rest O, Kok FJ, Brummer RJ, Van Boxtel MP, Verhoef P. n-3 Fatty acid proportions in plasma and cognitive performance in older adults. Am J Clin Nutr. 2007;86:1479-85.
52. Thelen KM, Laaksonen R, Päivä H, Lehtimaki T, Lütjohann D. Highdose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. J Clin Pharmacol. 2006;46:812-6.
53. Wagstaff LR, Mitton MW, Arvik BM, Doraiswamy PM. Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy. 2003;23:871-80.
54. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
55. Kostis JB, Rosen RC, Wilson AC. Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia. J Clin Pharmacol. 1994;34:989-96.
56. Harrison RW, Ashton CH. Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers. Br J Clin Pharmacol. 1994;37:231-6.
57. Cutler N, Sramek J, Veroff A, Block G, Stauffer L, Lines C. Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia. Br J Clin Pharmacol. 1995;39:333-6.
58. Miettinen TA, Strandberg TE, Gylling H. Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol. Arterioscler Thromb Vasc Biol. 2000;20:1340-6.
59. Connor WE, Lin DS, Pappu AS, Frohlich J, Gerhard G. Dietary sitostanol and campestanol: accumulation in the blood of humans with sitosterolemia and xanthomatosis and in rat tissues. Lipids. 2005;40:919-23.